Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial
The American heart journal, 2022-11, Vol.253, p.86-98 [Peer Reviewed Journal]2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022. The Authors ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2022.05.010 ;PMID: 35595091
Full text available